- Research works
- 49 ▼ 46% vs 2013–17
- Citations
- 1.1k 21.9 per fractional work
- Top-10% rate
- 12.1% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Prothena (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 5.4×. Every wedge is a field page.
Which keywords describe research at Prothena (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Treatment, Diagnosis, Prognosis, Cardiac Amyloidosis, Transthyretin, Neurodegeneration, Oxidative Stress and Neuroinflammation.
- Integrins
- Microglia
- Cell Adhesion
- Therapeutic Antibodies
- Glycosylation
- Cost-effectiveness Analysis
- Innate Immunity
- a-Synuclein
- Genetic Risk Factors
- phosphate
- Dopaminergic Neurons
- Virtual Screening
- Molecular Docking
- Parkinson's Disease
- Inflammation
- Tau Pathology
- Neuroinflammation
- Neurodegeneration
- Cardiac Amyloidosis
- Diagnosis
- Treatment
- Prognosis
- Transthyretin
- Oxidative Stress
- Amyloid Hypothesis
- Chronic Kidney Disease
- Machine Learning
- Quality of Life
- Pharmacokinetics
- Diagnostic Criteria
- FGF23
- Mitochondrial Dysfunction
- Neurological Disorders
- Angiogenesis
- Monoclonal Antibodies
- Fc Receptors
- Health Utility Measures
- Brain Development
- Cytokines
- Focal Adhesion Kinase
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Treatment14▲ 23×7 topics
- Diagnosis14▲ 28×5 topics
- Prognosis14▲ 87×4 topics
- Cardiac Amyloidosis14▲ 1395×1 topic
- Transthyretin14▲ 1395×1 topic
- Neurodegeneration8▲ 53×6 topics
- Oxidative Stress7▲ 7.8×6 topics
- Neuroinflammation7▲ 51×4 topics
- Amyloid Hypothesis5▲ 191×1 topic
- Tau Pathology5▲ 191×1 topic
- Chronic Kidney Disease3▲ 23×2 topics
- Inflammation3▲ 2.3×9 topics
- Machine Learning3▲ 2.5×4 topics
- Parkinson's Disease3▲ 23×6 topics
- Quality of Life2▲ 3.5×4 topics
- Molecular Docking2▲ 31×1 topic
- Pharmacokinetics2▲ 16×2 topics
- Virtual Screening2▲ 63×1 topic
- Diagnostic Criteria2▲ 21×4 topics
- Dopaminergic Neurons2▲ 63×2 topics
- FGF232▲ 110×1 topic
- phosphate2▲ 110×1 topic
- Mitochondrial Dysfunction2▲ 9.8×3 topics
- Genetic Risk Factors2▲ 67×1 topic
- Neurological Disorders2▲ 4.9×8 topics
- a-Synuclein2▲ 67×1 topic
- Angiogenesis1▲ 6.8×4 topics
- Innate Immunity1▲ 7.4×4 topics
- Monoclonal Antibodies1▲ 19×2 topics
- Cost-effectiveness Analysis1▲ 33×1 topic
- Fc Receptors1▲ 24×1 topic
- Glycosylation1▲ 11×2 topics
- Health Utility Measures1▲ 33×1 topic
- Therapeutic Antibodies1▲ 19×1 topic
- Brain Development1▲ 12×2 topics
- Cell Adhesion1▲ 26×2 topics
- Cytokines1▲ 8.1×2 topics
- Microglia1▲ 25×2 topics
- Focal Adhesion Kinase1▲ 35×1 topic
- Integrins1▲ 35×1 topic
Which research topics does Prothena (United States) publish most on?
By volume in 2022–2025: Alzheimer's disease research and treatments, Amyloidosis: Diagnosis, Treatment, Outcomes, Computational Drug Discovery Methods and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Alzheimer's disease research and treatments Physiology 2 works
- 2 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 2 works
- 3 Computational Drug Discovery Methods Computational Theory and Mathematics 2 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 5 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
- 6 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 7 Healthcare Operations and Scheduling Optimization Emergency Medical Services 0 works
- 8 Intracerebral and Subarachnoid Hemorrhage Research Neurology 0 works
- 9 14-3-3 protein interactions Molecular Biology 0 works
- 10 Gene expression and cancer classification Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Prothena (United States)'s research output changed?
Output in 2018–2022 was 46% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.